Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
105Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2014 | $0.00 | $-2.61M | $-6.12 |
| 2013 | $0.00 | $-798.1K | $-2.22 |
| 2012 | $227.7K | $-2.12M | $-14.43 |
| 2011 | $151.2K | $-71.2K | $-24.99 |
| 2010 | $177.4K | $-597.2K | $-274.20 |
Social Signal Score
Valuation
VRCIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newsproactiveinvestors.co.uk·4d ago·Neutral
Verici Dx gains Olink Certified Service Provider status to expand proteomics offering Verici Dx PLC (AIM:VRCI) has become an Olink Certified Service Provider, allowing the transplant diagnostics company to offer Olink-based proteomics assay services from its CAP-certified and CLIA-accredited laboratory. The certification, part of Thermo Fisher's Life Sciences Solutions network, enables Verici Dx to support biomarker discovery, algorithm development, validation, clinical trials and diagnostic app
View source ↗